Literature DB >> 28831749

PML-IRIS in an HIV-2-infected patient presenting as Bell's palsy.

Fabian Sierra Morales1,2, Carlos Illingworth3, Kathie Lin4, Ivia Rivera Agosto4, Chloé Powell4, Jacob A Sloane4, Igor J Koralnik5,6.   

Abstract

We present the case of an HIV-2-infected patient who developed progressive multifocal leukoencephalopathy (PML) in the setting of immune reconstitution inflammatory syndrome (IRIS) presenting as Bell's palsy. The brain MRI showed a single lesion in the facial colliculus considered initially to be ischemic in nature. This case report should alert clinicians that PML can occur in the setting of HIV-2 infection. It also illustrates the difficulty of establishing the diagnosis of PML.

Entities:  

Keywords:  Bell’s palsy; HIV-2; Immune reconstitution inflammatory syndrome; JC virus; Progressive multifocal leukoencephalopathy

Mesh：

Year:  2017        PMID： 28831749      PMCID： PMC5718171          DOI： 10.1007/s13365-017-0565-5

Source DB:  PubMed          Journal:  J Neurovirol        ISSN： 1355-0284            Impact factor:   2.643


  14 in total

1.  Progressive multifocal leukoencephalopathy in HIV-2 infection. Case report.

Authors:  Vítor Duque; Ana M Matos; J Saraiva da Cunha; A Meliço-Sivestre
Journal:  J Clin Virol       Date:  2010-05-07       Impact factor: 3.168

Review 2.  PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section.

Authors:  Joseph R Berger; Allen J Aksamit; David B Clifford; Larry Davis; Igor J Koralnik; James J Sejvar; Russell Bartt; Eugene O Major; Avindra Nath
Journal:  Neurology       Date:  2013-04-09       Impact factor: 9.910

3.  Dolutegravir in HIV-2-Infected Patients With Resistant Virus to First-line Integrase Inhibitors From the French Named Patient Program.

Authors:  Diane Descamps; Gilles Peytavin; Benoit Visseaux; Roland Tubiana; Florence Damond; Pauline Campa; Charlotte Charpentier; Marie-Aude Khuong-Josses; Claudine Duvivier; Marina Karmochkine; Tuna Lukiana; Sophie Matheron
Journal:  Clin Infect Dis       Date:  2015-02-17       Impact factor: 9.079

4.  Metabolic profile of PML lesions in patients with and without IRIS: an observational study.

Authors:  Sarah Gheuens; Long Ngo; Xiaoen Wang; David C Alsop; Robert E Lenkinski; Igor J Koralnik
Journal:  Neurology       Date:  2012-08-22       Impact factor: 9.910

5.  Detection of JC virus in two African cases of progressive multifocal leukoencephalopathy including identification of JCV type 3 in a Gambian AIDS patient.

Authors:  G L Stoner; H T Agostini; C F Ryschkewitsch; M Mazló; F Gullotta; W Wamukota; S Lucas
Journal:  J Med Microbiol       Date:  1998-08       Impact factor: 2.472

Review 6.  Neurologic Complications of Human Immunodeficiency Virus Infection.

Authors:  Avindra Nath
Journal:  Continuum (Minneap Minn)       Date:  2015-12

7.  The mortality and pathology of HIV infection in a west African city.

Authors:  S B Lucas; A Hounnou; C Peacock; A Beaumel; G Djomand; J M N'Gbichi; K Yeboue; M Hondé; M Diomande; C Giordano
Journal:  AIDS       Date:  1993-12       Impact factor: 4.177

8.  Diagnostic delay in progressive multifocal leukoencephalopathy.

Authors:  Dhanashri P Miskin; Long H Ngo; Igor J Koralnik
Journal:  Ann Clin Transl Neurol       Date:  2016-04-06       Impact factor: 4.511

Review 9.  Comparing HIV-1 and HIV-2 infection: Lessons for viral immunopathogenesis.

Authors:  Samuel Nyamweya; Andrea Hegedus; Assan Jaye; Sarah Rowland-Jones; Katie L Flanagan; Derek C Macallan
Journal:  Rev Med Virol       Date:  2013-02-26       Impact factor: 6.989

10.  HIV-2 diagnosis and quantification in high-risk patients.

Authors:  Philip A Chan; Sarah E Wakeman; Timothy Flanigan; Susan Cu-Uvin; Erna Kojic; Rami Kantor
Journal:  AIDS Res Ther       Date:  2008-08-14       Impact factor: 2.250
View more
  2 in total

Review 1.  Host-Immune Interactions in JC Virus Reactivation and Development of Progressive Multifocal Leukoencephalopathy (PML).

Authors:  Amir Khalili; Michael Craigie; Martina Donadoni; Ilker Kudret Sariyer
Journal:  J Neuroimmune Pharmacol       Date:  2019-08-27       Impact factor: 4.147

2.  Brainstem progressive multifocal leukoencephalopathy.

Authors:  Gautier Breville; Igor J Koralnik; Patrice H Lalive
Journal:  Eur J Neurol       Date:  2020-12-01       Impact factor: 6.089
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.